GENERIC 20541695

Download in:

Switch to

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027627, umls-concept:C0182953, umls-concept:C0598934, umls-concept:C0694883
pubmed:issue	6
pubmed:dateCreated	2010-6-14
pubmed:abstractText	In this issue of Cancer Cell, Carretero and colleagues report that Src and FAK signaling pathways are activated in lung cancers when the tumor suppressor LKB1 is deleted. These findings suggest the use of unique combinatorial therapies for treatment of lung cancers.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20541695-20541700
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101130617
pubmed:status	PubMed-not-MEDLINE
pubmed:month	Jun
pubmed:issn	1878-3686
pubmed:author	pubmed-author:DasilvaJohn OJO, pubmed-author:ParsonsSarah JSJ, pubmed-author:Slack-DavisJillJ
pubmed:copyrightInfo	Copyright 2010 Elsevier Inc. All rights reserved.
pubmed:issnType	Electronic
pubmed:day	15
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	527-9
pubmed:year	2010
pubmed:articleTitle	LKB1 and Src: antagonistic regulators of tumor growth and metastasis.
pubmed:affiliation	Department of Microbiology and Cancer Center, University of Virginia, Charlottesville, VA 22908, USA.
pubmed:publicationType	Journal Article, Comment